A pharmacometrics model to define docetaxel target in early breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pharmacometrics model to define docetaxel target in early breast cancer

Published:2022-09-28 Issue:2 Volume:89 Page:727-736
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Aldaz Azucena¹,Schaiquevich Paula²^ORCID,Aramendía José Manuel³⁴

Affiliation:

1. Pharmacy Service Clínica Universidad de Navarra Pamplona Navarra Spain

2. National Scientific and Technical Research Council (CONICET) Buenos Aires Argentina

3. Breast Cancer Unit, Medical Oncology Department Clínica Universidad de Navarra Pamplona Navarra Spain

4. IdiSNA, Navarra Institute for Health Research Pamplona Spain

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15526

Reference49 articles.

1. Which dosing scheme is suitable for the taxanes? anin vitro model

2. Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

3. Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

4. Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

5. Population Pharmacokinetic Model for Docetaxel in Patients with Varying Degrees of Liver Function: Incorporating Cytochrome P450 3A Activity Measurements

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Cross-sectional Comparative Analysis of Eleven Population Pharmacokinetic Models for Docetaxel in Chinese Breast Cancer Patients;Current Drug Metabolism;2024-08-16

2. Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines;International Journal of Molecular Sciences;2024-07-19

3. Oral docetaxel plus encequidar – A pharmacokinetic model and evaluation against IV docetaxel;Journal of Pharmacokinetics and Pharmacodynamics;2024-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3